Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort
NCT06279442 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2025-02-12
Summary
This is a retrospective observational cohort study. The clinical, pathological and treatment data of participants identified with adrenocortical carcinoma from the year 2000 onwards will be evaluated. Participants recruited for this study will be identified at the participating sites.
Conditions
- Carcinoma Adrenal
- Carcinoma, Adrenocortical Recurrent
Sponsors & Collaborators
-
Latin American Cooperative Oncology Group
lead OTHER
Principal Investigators
-
Milena Shizue Tariki · Latin American Cooperative Oncology Group
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-09
- Primary Completion
- 2025-08-25
- Completion
- 2025-08-25
Countries
- Brazil
Study Locations
More Related Trials
-
Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma
NCT00192829 ·Status: UNKNOWN
-
NM404 as an Imaging Agent in Patients With NSCLC
NCT00582283 ·Status: COMPLETED ·Phase: PHASE1
-
National Lung Cancer Registry in Men and Women Based on Diagnosis in Algeria
NCT02725892 ·Status: COMPLETED
-
Patient Journey With Advanced Lung Cancer Positive for ALK Fusion in Brazil
NCT04947683 ·Status: COMPLETED
-
The Alterations of Metabolic Adipo-myokines and Body Composition in End Stage Lung Cancer
NCT06060262 ·Status: RECRUITING
-
Characteristics of Advanced LUNG CANCER at the tIme of Diagnosis in a Large Italian Cohor
NCT06076005 ·Status: RECRUITING
-
Body Composition and Prognosis in Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT04003025 ·Status: WITHDRAWN
-
Prospective Evaluation of Immunological, Molecular-genetic, Image-based and Microbial Analyzes to Characterize Tumor Response and Control in Patients With Inoperable Stage III NSCLC Treated With Chemoradiotherapy Followed by Consolidation Therapy With Durvalumab
NCT05027165 ·Status: UNKNOWN
-
Personalizing Adoptive Cell Transfer for Solid Tumors: Towards a New Patient-tailored Treatment Option
NCT06922266 ·Status: NOT_YET_RECRUITING
-
Circulating Tumor DNA and T Cell Repertoire Predict Radiotherapeutic Outcomes in NSCLC Patients With Brain Metastasis
NCT05737589 ·Status: UNKNOWN
-
Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma
NCT04202614 ·Status: COMPLETED
-
Adrenal Function in Patients With Newly Diagnosed Lung Cancer
NCT00364624 ·Status: COMPLETED
-
Chinese Research Group of Gallbladder Cancer
NCT04140552 ·Status: RECRUITING
-
Broncho-Vascular Lung Sparing Reconstructions and Pneumonectomies in Patients With Non Small Cell Lung Cancer
NCT06835231 ·Status: ACTIVE_NOT_RECRUITING
-
National Network Genomic Medicine Lung Cancer, Germany
NCT05934032 ·Status: RECRUITING
-
Multiomics Approach in Metastatic Clear Renal Cell Carcnoma
NCT05782400 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Clinical, Radiomics and Molecular Features of Lung Metastasis in PDAC Patients (LUMACA Trial)
NCT04435067 ·Status: UNKNOWN
-
Radiomics and Radiogenomics of Non-small Cell Lung Cancer
NCT06331975 ·Status: COMPLETED ·Phase: NA
-
Oncologic and Functional Outcome and Quality of Life in Patients Treated for Laryngeal Cancer
NCT06784401 ·Status: ACTIVE_NOT_RECRUITING
-
Study of the Prognostic Impact of CD44 on Renal Cell Carcinoma
NCT06773377 ·Status: NOT_YET_RECRUITING
-
Analysis of Brain Metastasis in Patients With Lung Cancer
NCT00071344 ·Status: COMPLETED
-
Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer
NCT07288632 ·Status: RECRUITING
-
PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification
NCT05049837 ·Status: RECRUITING
-
Biomolecular Markers of Bone Metastasis
NCT06806462 ·Status: RECRUITING ·Phase: NA
-
PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
NCT04790253 ·Status: RECRUITING ·Phase: NA